Principal Global Investors' reduction below 5% removes a passive holder from the 5%+ roster. Monitor for further selling or a complete exit in future filings. The move is not necessarily bearish given the passive nature, but it reduces a stable institutional base.
Price Chart
Executive Summary
Principal Global Investors filed an amended Schedule 13G disclosing a 4.7% passive stake in Collegium Pharmaceutical as of September 30, 2026, down from a prior 5%+ position. The filing indicates the firm reduced its holdings below the 5% threshold, signaling a partial exit.
Key Financial Metrics
Key Facts
- Principal Global Investors reported beneficial ownership of 1,514,310 shares of Collegium Pharmaceutical common stock as of September 30, 2026.
- The stake represents 4.7% of shares outstanding, down from a prior 5%+ position disclosed in August 2026.
- The filing is an amendment to Schedule 13G, certifying passive intent under Rule 13d-1(b).
- The reduction below 5% means Principal Global Investors is no longer a 5% holder and may exit further.
Financial Impact
Principal Global Investors reduced its stake from above 5% to 4.7%, representing a decrease of at least 0.3% of shares outstanding. No dollar value of the reduction is stated.
Risk Factors
- Further selling by Principal Global Investors could pressure the stock if they continue to reduce their position.
- The filing does not disclose the exact date or price of the reduction, leaving the timing and magnitude of the sell-down unclear.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000769734-26-000057 |
| Document: 0000769734-26-000057-index.html | 0000769734-26-000057 |
| Document: 0000769734-26-000057.txt | 0000769734-26-000057 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | SC 13G/A | $24.23 | awaiting T+1 | awaiting T+1 | $23.80 (−1.77%) |
Oct 29, 2026 3d ago | SC 13G/A | $24.03 $23.80 | ▼ −0.96% | ▲ +0.82% | $23.80 (−0.96%) |
Oct 29, 2026 3d ago | Press Release | $24.03 $23.80 | ▼ −0.96% | ▲ +0.82% | $23.80 (−0.96%) |
Oct 22, 2026 10d ago | Press Release | $23.50 $22.96 | ▼ −2.30% | ▼ −1.78% | $23.80 (+1.28%) |
Oct 19, 2026 13d ago | 8-K | $23.23 $22.92 | ▼ −1.36% | ▼ −1.88% | $23.80 (+2.45%) |
Oct 8, 2026 24d ago | SC 13G/A | $22.09 $22.05 | ▼ −0.18% | ▼ −0.12% | $23.80 (+7.74%) |
Aug 19, 2026 10w ago | Court Ruling | $27.54 $27.11 | ▼ −1.56% | ▼ −1.97% | $23.80 (−13.58%) |
Aug 13, 2026 11w ago | 8-K | $28.15 $28.23 | ▲ +0.28% | ▲ +0.48% | $23.80 (−15.45%) |
Aug 6, 2026 12w ago | 8-K | $29.11 $29.47 | ▲ +1.24% | ▲ +0.63% | $23.80 (−18.24%) |
May 15, 2026 24w ago | Insider Cluster | $33.65 $33.62 | ▼ −0.09% | ▲ +0.56% | $23.80 (−29.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers